These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

908 related items for PubMed ID: 17653279

  • 1. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ.
    PLoS One; 2007 Jul 25; 2(7):e652. PubMed ID: 17653279
    [Abstract] [Full Text] [Related]

  • 2. In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.
    Jean L, Brimijoin S, Vaux DJ.
    J Biol Chem; 2019 Apr 19; 294(16):6253-6272. PubMed ID: 30787102
    [Abstract] [Full Text] [Related]

  • 3. Green Tea Seed Isolated Theasaponin E1 Ameliorates AD Promoting Neurotoxic Pathogenesis by Attenuating Aβ Peptide Levels in SweAPP N2a Cells.
    Khan MI, Shin JH, Kim MY, Shin TS, Kim JD.
    Molecules; 2020 May 16; 25(10):. PubMed ID: 32429462
    [Abstract] [Full Text] [Related]

  • 4. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
    Betts V, Leissring MA, Dolios G, Wang R, Selkoe DJ, Walsh DM.
    Neurobiol Dis; 2008 Sep 16; 31(3):442-50. PubMed ID: 18602473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY, Jannat S, Edraki N, Das S, Chang WK, Kim HC, Park SK, Chang MS.
    Chem Biol Interact; 2019 Aug 25; 309():108707. PubMed ID: 31194956
    [Abstract] [Full Text] [Related]

  • 8. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    Chen PT, Chen CL, Lin LT, Lo CH, Hu CJ, Chen RP, Wang SS.
    PLoS One; 2016 Aug 25; 11(4):e0153360. PubMed ID: 27096746
    [Abstract] [Full Text] [Related]

  • 9. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E.
    J Neurosci Res; 2006 May 15; 83(7):1252-61. PubMed ID: 16511867
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N, Ishikuro R, Tanida M, Suzuki K, Ikeda-Matsuo Y, Sobue K.
    Neuroscience; 2018 Aug 10; 385():227-236. PubMed ID: 29932983
    [Abstract] [Full Text] [Related]

  • 12. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.
    J Alzheimers Dis; 2015 Aug 10; 48(4):891-917. PubMed ID: 26444774
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of enzymatic degradation of amyloid Beta microfibrils generating nanofilaments and nanospheres related to cytotoxicity.
    Numata K, Kaplan DL.
    Biochemistry; 2010 Apr 20; 49(15):3254-60. PubMed ID: 20196618
    [Abstract] [Full Text] [Related]

  • 14. Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.
    Dorfman VB, Pasquini L, Riudavets M, López-Costa JJ, Villegas A, Troncoso JC, Lopera F, Castaño EM, Morelli L.
    Neurobiol Aging; 2010 Oct 20; 31(10):1743-57. PubMed ID: 19019493
    [Abstract] [Full Text] [Related]

  • 15. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
    Li B, Yu D, Xu Z.
    Brain Res; 2014 Jan 30; 1545():35-44. PubMed ID: 24333930
    [Abstract] [Full Text] [Related]

  • 16. Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates.
    Viayna E, Sabate R, Muñoz-Torrero D.
    Curr Top Med Chem; 2013 Jan 30; 13(15):1820-42. PubMed ID: 23931440
    [Abstract] [Full Text] [Related]

  • 17. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
    Tomita T.
    Adv Biol Regul; 2017 May 30; 64():33-38. PubMed ID: 28082052
    [Abstract] [Full Text] [Related]

  • 18. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M, Moore A, Naughton M, Boland B, Siems WE, Walther T.
    Neurosci Lett; 2018 Nov 01; 686():74-79. PubMed ID: 30144539
    [Abstract] [Full Text] [Related]

  • 19. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
    Alvarez A, Opazo C, Alarcón R, Garrido J, Inestrosa NC.
    J Mol Biol; 1997 Sep 26; 272(3):348-61. PubMed ID: 9325095
    [Abstract] [Full Text] [Related]

  • 20. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
    Hubin E, Cioffi F, Rozenski J, van Nuland NA, Broersen K.
    Biochim Biophys Acta; 2016 Jun 26; 1860(6):1281-90. PubMed ID: 26968463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.